Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation

Published:2012-11 Issue:11 Volume:18 Page:1687-1699
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Green Margaret L.,Leisenring Wendy,Stachel Daniel,Pergam Steven A.,Sandmaier Brenda M.,Wald Anna,Corey Lawrence,Boeckh Michael

Funder

Joel Meyers Endowment Fund

Infectious Disease Society of America Education and Research Foundation

National Foundation for Infectious Diseases Astellas Postdoctoral Fellowship in Transplant Infectious Diseases

Viropharma/ASBMT New Investigator Award

National Institutes of Health

Chimerix, Merck

Viropharma

GlaxoSmithKline

Gilead

Aicuris

Agenus

Vical

Chimerix

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference41 articles.

1. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study;Boeckh;Blood,1996

2. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective;Tomblyn;Biol Blood Marrow Transplant,2009

3. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations

4. An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients;Pollack;Biol Blood Marrow Transplant,2011

5. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture;Boeckh;Transplantation,1997

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abordagem à Infeção pelo Vírus Citomegálico em Doentes Submetidos a Transplante Alogénico de Progenitores Hematopoiéticos;Acta Médica Portuguesa;2024-07-15

2. Late cytomegalovirus disease after hematopoietic cell transplantation: significance of novel transplantation techniques;Blood Advances;2024-07-11

3. Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan;Clinical Drug Investigation;2024-06-27

4. Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighting the Role of Advanced Practice Providers (Nurse Practitioners and Physician Assistants);Annals of Transplantation;2024-03-15

5. Gaining Consensus Around Patient Risk Groups and Prognostic Profiles to Guide CMV Management Among Patients With Allogeneic Hematopoietic Stem Cell Transplant: Insights From a Delphi Panel With Hematopoietic Stem Cell Transplant Experts;Transplantation Proceedings;2024-03